Similarly, tumor necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) undergo glycosylation changes in AD, influencing receptor affinity and downstream signaling [32,33,34]. This evidence concerns the gene TNF and Alzheimer disease.